Clinical data
ATC code
  • none
  • [2-(1H-indol-3-yl)ethyl]-N-propyl-N-isopropylamine
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
Molar mass244.382 g·mol−1
3D model (JSmol)
  • CC(C)N(CCC)CCc2c[nH]c1ccccc12
  • InChI=1S/C16H24N2/c1-4-10-18(13(2)3)11-9-14-12-17-16-8-6-5-7-15(14)16/h5-8,12-13,17H,4,9-11H2,1-3H3 checkY
 ☒NcheckY (what is this?)  (verify)

Propylisopropyltryptamine (PiPT) is a chemical in the tryptamine family, which reportedly produces psychedelic and hallucinogenic effects that resemble those of other related dialkyl tryptamine derivatives,[1] although PiPT is reportedly relatively weak and short lasting. It has been sold as a designer drug, first being identified in 2021 in British Columbia, Canada.[2]


PiPT is short for N-propyl-N-isopropyl-tryptamine. PiPT is a tryptamine, which all belong to a larger family of compounds known as indolethylamines. PiPT is closely related to the compounds DPT and DiPT.


PiPT is reported as being active at doses of 50-100mg orally, or 25mg smoked.[citation needed]


Very little is known about the psychopharmacological properties of PiPT, but reports suggest it produces psychedelic effects similar to those of other hallucinogenic tryptamine derivatives, that can last around 2-4 hours.[citation needed]


There have been no reported deaths or hospitalizations from PiPT, but its safety profile is unknown.[citation needed]


PiPT is unscheduled and uncontrolled in the United States, but possession and sales of PiPT could be prosecuted under the Federal Analog Act because of its structural similarities to other hallucinogenic tryptamine derivatives.

See also


  1. ^ Catalani V, Corkery JM, Guirguis A, Napoletano F, Arillotta D, Zangani C, Vento A, Schifano F (August 2021). "Psychonauts' psychedelics: A systematic, multilingual, web-crawling exercise". European Neuropsychopharmacology. 49: 69–92. doi:10.1016/j.euroneuro.2021.03.006. hdl:2299/24309. PMID 33857740. S2CID 233206904.
  2. ^ Knill A, Tobias S, Matthews J, Ti L (June 2022). A Report on British Columbia’s Unregulated Drug Supply. Drug checking trends across British Columbia, January to December 2021 (PDF). British Columbia Centre on Substance Use (Report).